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Abstract
Introduction Regional brain volume estimation in multiple
sclerosis (MS) patients is prone to error due to white matter
lesions being erroneously segmented as grey matter. The
Lesion Segmentation Toolbox (LST) is an automatic tool that
estimates a lesion mask based on 3D T2-FLAIR images and
then uses this mask to fill the structural MRI image. The goal
of this study was (1) to test the LST for estimating white
matter lesion volume in a cohort of MS patients using 2D
T2-FLAIR images, and (2) to evaluate the performance of
the optimized LST on image segmentation and the impact on
the calculated grey matter fraction (GMF).
Methods The study included 110 patients with a clinically
isolated syndrome and 42 with a relapsing-remitting MS
scanned on a 3.0-T MRI system. In a subset of consecutively
selected patients, the lesion mask was semi-manually delin-
eated over T2-FLAIR images. After establishing the opti-
mized LST parameters, the corresponding regional fractions
were calculated for the original, filled, and masked images.
Results A high agreement (intraclass correlation coefficient
(ICC)=0.955) was found between the (optimized) LST and
the semi-manual lesion volume estimations. The GMF was
significantly smaller when lesions were masked (mean differ-
ence −0.603, p<0.001) or when the LST filling technique was
used (mean difference −0.598, p<0.001), compared to the
GMF obtained from the original image.
Conclusion LST lesion volume calculation seems reliable.
GMFs are significantly reduced when a method to correct
the contribution of MS lesions is used, and it may have an
impact in assessing GMF differences between clinical cohorts.
Keywords Multiple sclerosis . Brain atrophy . Lesion
segmentation . Brain volume
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Multiple sclerosis (MS) is a chronic inflammatory disease of
the central nervous system that causes inflammation, demye-
lination, axonal loss, and gliosis [1]. Brain magnetic reso-
nance imaging (MRI) findings in MS patients include the
presence of multifocal demyelinating lesions in white matter
(WM) regions [2, 3], reflecting the inflammatory component
of the disease. Global and regional brain volume loss due to
the degenerative component of the condition has prompted
considerable research [4, 5], as these measures correlate with
MS-related disability progression and cognitive impairment.
The grey matter (GM) volume loss correlates more closely
with clinical measures thanWM loss [6], and efforts are being
directed toward achieving accurate GM measurements.
Regional brain volume estimates based on image segmen-
tation techniques in MS patients are prone to error because of
the aforementioned multifocal T2-hyperintense WM lesions.
The intensity of WM lesions may be closer to GM intensity
than to normal-appearing WM, and a number of these lesions
are erroneously classified as GM, thereby adding to the esti-
mated GM volume [7, 8]. Moreover, these T2-hyperintense
WM lesions slightly modify the cutoff values derived from the
tissue intensity histogram used to segment the different brain
compartments [8].
A few years ago, the Lesion Segmentation Toolbox (LST)
was developed [9]. This software package estimates a lesion
mask based on 3D T1-weighted and T2-FLAIR images and
uses the mask to fill in the structural MRI. The LST was
originally designed for MS patients undergoing 3D T2-
FLAIR image acquisition on a 3.0-T MRI system. However,
optimized 3D T2-FLAIR sequences are not available on all
scanners. 2D FLAIR images, which typically have lower res-
olution and different image contrast, are more commonly
available. The LST has been validated using 2D T2-FLAIR
images acquired on a 1.5-TMRI system in a cohort of patients
with diabetes [10], but it has not been tested in similar images
acquired in MS patients. The aims of study are to assess the
production of lesion masks with the LST software using 2D
T2-FLAIR images acquired on a 3.0-T MRI system in a co-
hort of MS patients, and to evaluate the results obtained when
the masks are used in the LST lesion filling procedure in terms
of GM and WM voxel classification and calculation of the
WM and GM fractions (WMF, GMF).
Material and methods
Patients
The study included MRI scans from 110 patients with a clin-
ically isolated syndrome (CIS), 64%women, with a mean age
of 34 years (SD 8), mean expanded disability status scale
(EDSS) score of 1.8 (SD 1.1), and mean disease duration of
4.5 months, and from 42 relapsing-remitting MS patients
(RRMS), 62 % women, with a mean age of 38 years (SD 7),
mean EDSS of 2.6 (SD 1.7), and mean disease duration of
10.5 years (SD 7.7). The study was approved by the local ethics
committee and patients gave informed consent to participate.
MRI acquisition
MR imaging was performed on a 3.0-T MRI magnet with a
12-channel phased-array head coil (Trio Tim, Siemens,
Germany). The following pulse sequences were obtained:
(1) transverse proton density and T2-weighted fast spin-echo
(repetition time [TR]=2500 ms/echo time [TE]=16/91 ms;
voxel size = 0.78 × 0.78 × 3.0 mm3, (2) transverse fast T2-
FLAIR (TR=9000 ms, TE=93 ms, TI= 2500 ms, flip an-
gle=120°, voxel size=0.49×0.49×3.0 mm3), and (3) sagittal
3D T1 magnetization prepared rapid gradient-echo
(MPRAGE) (TR=2300 ms, TE=2 ms; flip angle=9°; voxel
size=1.0×1.0×1.2 mm3).
Image analysis
A general scheme of the analysis pipeline is included in Fig. 1.
Each step is described in more detail in their corresponding
section.
Generation of reference lesion masks
In a subset of consecutive CIS patients (n=33), a mask was
semi-manually delineated over 2D T2-FLAIR images by a
trained technician using the JIM software and a semi-
automatic tool, version 6 (Xynapse Systems Ltd, UK). Awide
range of lesion volumes was included in this subgroup (mean
(SD) = 4.6 ml (8.1), range 0–43 ml). The technician was
blinded to the purpose of the study. These constituted the
reference ground truth (GT) lesion masks.
LST optimization
WM lesion masks were generated using the LST for Statistical
ParametricMapping (SPM8, http://www.fil.ion.ucl.ac.uk/spm)
after parameter optimization. Two LST parameters were
optimized: κ, a cutoff value to generate the initial lesion
probability maps; and th, which enables transformation of
these probability maps into binary images. The Blesion belief
map^ chosen was GM. A lesion mask was generated for the
100 combinations tested: 20 κ values (0.025 intervals, range
(0.100, 0.575)) and 5 th (0.2 intervals, range (0.2, 1)). The
lesion mask generated was then compared with the GT mask
using the LST module Bdetermination of initial threshold.^
This module calculates the similarity of measures of
sensitivity, specificity, and the Dice coefficient (DC) between
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the two masks (GT, LST). Selection of the optimum κ and th
values was based on maximizing the DC value.
GM and WM segmentation
Once the parameters were optimized, the LSTwas implemented
and a filled structural image was obtained for each patient. The
lesions depicted in the 2D T2-FLAIR mask were in-painted on
the resulting filled structural image. Both the original and filled
images were segmented following the voxel-based morphome-
try (VBM8) DARTEL approach [11, 12], available for SPM8.
Briefly, images were segmented with the help of six tissue clas-
ses—grey matter, white matter, cerebro-spinal fluid, bone, non-
brain soft tissue, and air outside of the head and in nose, sinus,
and ears—in both the native and Montreal Neurological
Institute (MNI) space. Normalized images to the MNI space
were modulated and non-linearly warped (default settings in
VBM8). An additional approach was tested, in which the LST
lesion mask was directly applied to the original structural image
using the masking procedure available in VBM8. This (third)
anatomical image was also segmented and normalized to the
MNI space, following the same procedure stated for the filled
and original image. After segmentation, the corresponding
GMF and WMF were calculated for each patient from the seg-
mented images in the native space (by dividing by the total
intracranial volume). The difference in the GMF and WMF
estimations from masked and original images with respect the
filled image was also calculated according to the following for-
mula: PctDiffGMFf-m = 100*(GMFfilled-GMFmasked)/
GMFfil led and PctDiffGMFf-o = 100*(GMFfil led-
GMForiginal)/GMFfilled. The correspondingWMF percentage
difference was calculated by replacing the GMF by the WMF
value. The percentage difference between the masked and orig-
inal, with respect to the masked value, was also calculated for
GMF (and for WMF, with appropriate substitutions) using the
formula PctDiffGMFm-o=100*(GMFmasked-GMForiginal)/
GMFmasked.
In addition, the DC was computed between the segmented
GM images and the segmented GM of the filled image (orig-
inal versus filled, masked versus filled). Lastly, normalized
GM images to the MNI space were used to generate the map
of mean differences. First, two (normalized) subtraction GM
images were obtained for each subject (filled-original and
filled-masked) using SPM8, and the subtraction images for
all subjects were averaged to generate the corresponding
map of differences. Positive differences in this map represent-
ed voxels included in the GM segmentation of the filled image
that were not in the original/masked image, whereas negative
differences were voxels included in GM segmentation of the
original/masked image and not in the filled one. The aim of
this map was to assess the regional distribution of the
differences.
Statistical analysis
Statistical analysis was performed using the Statistical
Package for the Social Sciences (SPSS, IBM, USA).
First, the distribution of the LST lesion volume (LV)
and the GT LV were tested for normality with the
Shapiro–Wilk test. As distributions were not normal, the
relationship between LST and GT LVs was studied using
the Spearman test. Linear regression analysis between
LST lesion volume (LV) and GT LV was performed,
and the intraclass correlation coefficient (ICC) for the
two measures was calculated as a measure of concor-
dance. To determine whether the calculated differences
(PctDiffGMFf-m, PctDiffGMFf-o, PctDiffGMFm-o,
PctDiffWMFf-m, PctDiffWMFf-o, PctDiffWMFm-o) dif-
fered from zero, a one-sample t test was applied. To in-
vestigate correlations with the LV, a Spearman correlation
test was run between the calculated differences and the
LV. Regarding the DC calculated for the segmented GM
images, the dependence of the agreement on the LV was
tested using a Spearman correlation test. Finally, differ-
ences in estimated GMF for CIS patients versus RRMS
patients were compared using one-way analysis of vari-
ance (ANOVA), with MS type (CIS or RRMS) as a factor.
ANOVA was applied to the GMF calculated from the
original, masked, and filled images. Correlations between
GMF/WMF and EDSS were assessed using the Spearman
test. Significance level was set at p< 0.05.






FLAIR, fluid attenuated inversion
recovery; GT, ground truth; GM,
grey matter; WM, white matter;
CSF, cerebro-spinal fluid; o,
original; f, filled; m, masked
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Results
Optimization of LST parameters and LV estimation
For each combination of κ and th, the corresponding LV was
calculated and compared to the GT LV. The mean sensitivity,
specificity, and DC obtained for the best combination of pa-
rameters are reported in Table 1. Results in Table 1 have also
been divided as a function of the LV. For 1<LV<5 ml, the
highest DC was obtained when κ=0.125 and th=1.0; for
volumes above 5 ml, κ=0.175 and th=1.0. The average value
of κ=0.15 was chosen.
A highly significant correlation was found (rho=0.95 and
p<0.0001) between LSTand GT LVs. The computed ICC was
0.955, indicating high agreement between the GT LVand LST
LV values (Fig. 2). Figure 2 also includes the fitted regression
line (slope=1.198, 95 % confidence interval 1.100–1.296,
p<0.001; intercept=−0.015, 95%CI -0.911-0.881, p=0.973).
Two LSToutput examples are displayed in Fig. 3. In the first
case (upper row), the agreement is very high (GT LV=7.01 ml,
LST LV=7.00 ml; DC between lesion masks=0.71) while in
the second case (lower row), which was an extreme case, the
LV was underestimated a 33 % (GT LV=7.13 ml and LST
LV=4.80 ml; DC=0.35). The black arrows point to the missed
hyperintense points in the FLAIR marked by LST (second col-
umn), as well as to resulting not in-painted hypointensities in
the filled MPRAGE (third column). Red arrows point to the
hyperintensities in the FLAIRmarked by LST (second column)
that were not part of the GT.
GM and WM segmentation
The lesion masks, and the GM and WM segmentation
obtained using optimized κ= 0.15 and th= 1.0 were vi-
sually verified by an experienced technician in a ran-
dom group of patients (n= 40). Differences in estimated
GMF and WMF for the original and masked images
compared to the filled ones and between the original
and masked images are reported in Fig. 4 against LV.
The goal of these graphs was to assess the tendency of
the calculated percentage difference according to in-
creasing values of LV.
The percentage difference of original compared to filled
(PctDiffGMFf-o), and original compared to masked
(PctDiffGMFm-o) both differed significantly from zero (mean
difference −0.598 and −0.603, respectively; p<0.001), where-
as PctDiffGMFf-m did not (mean difference 0.003; p=0.967).
The same pattern was seen for the WMF: PctDiffWMFf-o and
PctDiffWMFm-o both differed significantly from zero (mean
difference 0.791 and 0.713, respectively; p<0.001), whereas
PctDiffWMFf-m did not (mean difference 0.074; p=0.208). In
a separate analysis including only cases in whom LV >5 mL,
themean difference increased in all cases, but the tendencywas
the same (data not shown). The same occurred when only cases
with LV >10 mL were included (data not shown).
In cases showing a small LV (<5 mL), we obtained both
positive and negative GMF differences between original im-
ages with respect to the filled images, although most cases
were negative (80 %). Negative differences indicate that
GMF in the original images was overestimated relative to
GMF in the filled image. The opposite pattern (most cases with
positive differences) was seen in WMF, indicating underesti-
mation of WMF using the original images. Only a small num-
ber of cases with LV <5 mL showed a negative WMF differ-
ence. The percentage difference increased as LV increased
(negative for GMF; Spearman coefficient rho = −0.600,
p < 0.0001), positive for WMF rho = 0.843, p < 0.0001;
Fig. 4). When masked images were compared to the original
images with respect to the masked images, a similar pattern
was observed (GMF rho = −0.480, p < 0.0001; WMF
rho=0.710, p<0.0001; Fig. 4).When GMF andWMF obtain-
ed frommasked images were compared to the GMF andWMF
from filled images, with respect the GMF and WMF from
filled images, there was no clear relationship between the per-
centage difference in GMF or WMF and the LV (GMF
rho=−0.159, p=0.085; WMF rho=0.041; p=0.655; Fig. 4).
The calculated DCs for segmented GM images of original
versus filled, masked versus filled, and masked versus original
are reported in Fig. 5. This graph depicts the degree of agree-
ment between two segmented GM images, as a function of the
LV. The goal was to show a decrease in the agreement, as the
LV increases, which was more pronounced when filled or
masked images were compared to the original image. The
three figures were scaled to the same minimum DC value.
There was a significant association between the degree of
agreement between the segmented GM images and the LV in
the three cases (Spearman coefficient and significance): orig-
inal compared to filled images (−0.388, p<0.0001), masked
Table 1 Statistics of similarity
between LST lesion masks and
semi-manual FLAIR-based lesion
masks (GT)
n κ th Sensitivity Specificity DC
GT LV ≤1 mL 14 0.125 0.25 0.21 (0.00–0.54) 1.000 (0.999–1.000) 0.23 (0.00–0.60)
1 <GT LV ≤ 5 mL 10 0.125 1.0 0.56 (0.36–0.69) 0.998 (0.993–1.000) 0.51 (0.32–0.73)
GT LV >5 mL 9 0.175 1.0 0.64 (0.26–0.87) 0.997 (0.992–0.999) 0.64 (0.34–0.83)
The mean (range) is given for the sensitivity, specificity, and DC
LV lesion volume, GT ground truth, n group size, κ kappa, th threshold, DC dice coefficient
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compared to filled images (−0.521, p<0.0001), and original
compared to masked (−0.544, p<0.0001).
Regarding the spatial distribution of the differences in
segmented GM images, the comparison of filled with
masked or filled with original images showed that both
positive and negative differences were mainly located
along the GM/WM boundary (Fig. 6). Negative differ-
ences in both comparisons were also found in areas
between the temporal poles, where the hypophysis and
the optic nerve are located. When the segmented GM of
filled images was subtracted from the segmented GM of
masked images, additional positive differences were
found in the caudate, fornix, and periventricular WM.
When the segmented GM of filled images was
subtracted from the segmented GM of the original im-
ages, there were additional negative differences in WM
regions, which corresponded to (unremoved) brain le-
sions in the original GM segmented image.
Finally, GMFs obtainedwith the three different methodswere
compared between CIS and RRMS patients. When mean (SD)
GMF values calculated from original images were compared
between groups (GMFCIS=0.484 (0.020), GMFRRMS=0.477
(0.021)), the differences did not reach statistical significance;
only a trend was observed for a lower GMF in the RRMS group
(p = 0.075). When GMF values calculated from masked
(GMFCIS=0.483 (0.020), GMFRRMS=0.471 (0.021)) or filled
images (GMFCIS=0.483 (0.019), GMFRRMS=0.473 (0.021))
were compared, GMFRRMS was significantly lower than
GMFCIS, in both cases (p=0.005 and p=0.021, respectively).
Correlations between GMF/WMF and EDSS were not signifi-
cant for any of the three methods procedures (original, masked,
filled).
Discussion
This study presents a validation of the LST, an automated
toolbox that estimates a lesion mask and in-paints the struc-
tural images [9], in a cohort of CIS and RRMS patients. The
present validation includes a step to optimize the toolbox
Fig. 2 Scatterplot of the GT versus the LST LV for all patients included in the optimization analysis (left) and a detail for cases with LV<10mL (right).
The fitted regression line is also included. Abbreviations: GT, ground truth; LV, lesion volume; LST, Lesion Segmentation Toolbox
           GT LV = 7.01 ml      DICE = 0.71    LST LV = 7.00 ml      
GT LV = 7.13 ml    DICE = 0.35    LST LV = 4.80 ml 
Fig. 3 Examples of LSToutput. The first row shows a case of very high
agreement between estimated lesion volumes GT (LV= 7.01ml) and LST
(LV = 7.00 ml), and a high agreement in the generated lesion masks
(DC = 0.71). The second row shows an extreme example of low
agreement, where the LV was underestimated a 33 % (GT
LV = 7.13 ml and LST LV= 4.80 ml; DC = 0.35). The black arrows
point to the missed hyperintense points in the FLAIR marked by LST
(second column), as well as in the filled MPRAGE (third column). Red
arrows point to the hyperintensities in the FLAIR marked by LST
(second column) that were not part of the GT. Images are in
neurological convention (R is R, L is L). Abbreviations: GT, ground
truth; LV, lesion volume; LST, lesion segmentation toolbox; DC, dice
coefficient; FLAIR, fluid attenuated inversion recovery; R, right; L, left
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parameters for 2D-FLAIR images, acquired on a 3.0-T MRI
system. In addition, the study quantifies the impact of T2-
hypointense WM lesions on the GM segmentations and the
calculated GMF.
Fig. 4 Relationship between
LST LVand the percent
difference in the estimated GMF
(filled circles) and WMF (open
circles). In the upper row, masked
images were compared with filled
images; in the middle row,
original images were compared
with filled images; and in the
lower row, original images were
compared with masked images.
Abbreviations: LST, Lesion
Segmentation Toolbox, LV, lesion
volume; GMF, grey matter
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Fig. 5 Calculated DC between segmented GM from the original and filled images (left), the masked and filled images (center), and the masked and
original image (right) according to the LV. Abbreviations, DC, Dice coefficient; GM, grey matter; LV, lesion volume
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Optimization of LST parameters and LV estimation
The optimized parameters to enable LST use in conjunction
with the 2D-FLAIR images obtained in this study differ from
those reported for 3D-FLAIR images [9], even though both
sets of parameters were acquired using 3.0-T MRI. In any
case, the DC reported value by Schmidt [9] for κ=0.15 is only
2 % lower than the one reported for κ=0.30, the value con-
sidered optimum for 3D-FLAIR images. Another recent study
optimized LST for patients with diabetes [10] also using 2D-
FLAIR images, which were acquired on a 1.5-T MRI system.
The optimized parameters differ from the ones reported by
Schmidt and the ones we obtained, suggesting that lesion
mask estimation with the LST depends on both the FLAIR
acquisition configuration (2D vs 3D) and the field strength
(1.5 vs 3.0 T). The WM LV of the cohort studied is likely
another relevant factor, as our results indicate. As the LST is
supposed to be used without knowing a priori the LV, we
chose an intermediate value between the optimized κ value
for 1 <LV<5 mL (κ= 0.125) and LV>5 mL (κ= 0.175),
which yielded a value of κ=0.15 and th=1.0. In the present
study, the agreement obtained between the GT and the lesion
masks generated (ICC=0.955) was slightly higher than the
reported value for 3D-FLAIR images (ICC = 0.67 for
LV>5 ml and ICC=0.85 for LV>15ml). A higher frequency
of cases with low LV may explain the lower ICC reported in
the diabetes study, as well as the fact that topography of le-
sions in diabetes differs from MS (for which LST was
optimized).
Optimization of automated tools to estimate LV greatly
depends on the accuracy of the GT lesion masks. Our GTs
were generated from 2D-FLAIR images by a trained techni-
cian with more than 10 years’ experience and were verified by
an experienced neuroradiologist. Finally, even though LST
performance is likely less accurate for small lesion volumes,
we included CIS patients because MR characterization of
these patients is clinically relevant. Still, further work is
needed to validate the newer version of LST, which includes
an algorithm that does not need any optimization step, and
also to assess its validity in longitudinal studies, before this
tool can be included in routine practice.
GM and WM segmentations
As was expected, the difference in segmented GMF
when original images were compared to filled ones be-
came larger as the LV increased, and the GMF of filled
images was lower than the GMF of the original ones
except in a minority of cases with a small LV (<5 mL).
Thus, use of the LST filling approach to correct for the
presence of lesions lowered the estimated GMF, and this
reduction was linearly dependent on the LV. These re-
sults are in the line with those reported by Gelineu-
Morel [13] in a study using simulated WM lesions. As
expected too, the opposite occurred for WMF, where
correcting for the lesion contribution enlarged the calcu-
lated WMF, also as a linear function of the LV.
Estimated differences in calculated GMF and WMF be-
tween original and masked images showed similar
trends and, again, a linear behavior with the LV (nega-
tive slope for GMF, positive slope for WMF). The GMF
and WMF differences seen when values from masked
and filled image were compared did not show a linear
dependency on the LV. However, in most cases, GMF
and WMF estimations using the masking procedure
were closer to estimations using the original images
than those using filled images. This may indicate that
the use of filled images favorably affects the impact of
WM lesion on segmentation.
Visual representation of the voxels classified as GM
in the filled image and not in the original/masked image
reflect an almost continuous distribution along the GM/
WM border. This can be explained, in part, by the fact
that the histograms used to derive the cutoff values of
Fig. 6 Maps showing segmented
GM differences in filled versus
original (left) and filled versus
masked (right). Maps were
overlaid over a mean (filled) 3D




the different compartments during the segmentation step
differed: the original image included all the points of
the image, and the masked approach removed the points
belonging to the lesion mask. Different histograms will
lead to slightly different segmentation results. This ef-
fect could also explain the negative differences located
around the temporal poles. In this location, voxels were
classified as GM in the original and masked images, but
not in the filled image.
Finally, regarding the effect in clinical studies, GMF
differences between CIS and RRMS were not significant
when GMF from the original images were compared,
whereas differences reached significance when masked
and filled images were used in the comparisons. These
results support the need to use a correction approach in
brain tissue segmentation in MS patients in clinical
studies to avoid lesion-volume-dependent overestimation
of the GMF. Taken together, our results suggest that the
use of a method to correct the impact of lesions on
segmentation outputs improves the calculation of GMF
and WMF in MS patients and should be recommended.
Further work is needed to incorporate these tools into a
seamless fully automated algorithm which could be val-
idated and readily applied in clinical practice. In addi-
tion, further work is also needed to assess the effect of
lesion correction in the correlation with other relevant
clinical parameters.
Conclusions
Our results indicate that LST produces reliable lesion volume
masks that can be readily incorporated in brain segmentation
algorithms. Using these algorithms, estimated GMF is signif-
icantly smaller when lesions are removed from the image or
when the LST filling technique is used, with a marginal ben-
efit for the latter. This is of high relevance in clinical studies
since, in this work, GMF differences between CIS and RRMS
only became significant when such approaches were used.
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